Trial in progress: A phase 1b study of sotorasib, a specific and irreversible KRAS(G12C) inhibitor, as monotherapy in non-small cell lung cancer (NSCLC) with brain metastasis and in combination with other anticancer therapies in advanced solid tumors (CodeBreaK 101) Meeting Abstract
| Authors: | Hong, D. S.; Strickler, J. H.; Fakih, M.; Falchook, G. S.; Li, B. T.; Durm, G. A.; Burns, T. F.; Ramalingam, S. S.; Goldberg, S. B.; Frank, R. C.; Marrone, K.; Shu, C. A.; Gandara, D. R.; Soman, N.; Henary, H. A.; Govindan, R. |
| Abstract Title: | Trial in progress: A phase 1b study of sotorasib, a specific and irreversible KRAS(G12C) inhibitor, as monotherapy in non-small cell lung cancer (NSCLC) with brain metastasis and in combination with other anticancer therapies in advanced solid tumors (CodeBreaK 101) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120306208 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS2669 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS2669 -- Source: Wos |
